VRTX (NASDAQ: VRTX) files Form 144 to sell 40,000 common shares

NodeGuardian · 2026-03-16T20:40:05+00:00

Vertex Pharmaceuticals Inc. has filed a Form 144 for the sale of 40,000 common shares worth approximately $19.7 million, with some shares vesting in early 2025 and Fidelity Brokerage Services as the broker.

NodeGuardian

2026-03-16 20:40:05

Abstract generation in progress

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has filed a Form 144 to propose the sale of 40,000 common shares, valued at an aggregate of $19,738,905.28. The filing indicates several restricted stock vesting dates in early 2025 contributing to these shares and lists Fidelity Brokerage Services LLC as the broker. The common shares are listed on NASDAQ.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.